ArticleDrugs in R&D2021

Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment.

Charles E Frost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.